NKTX - Nkarta, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
South San Francisco,
United States
Type: Equity
NKTX price evolution
NKTX
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $123.14 | $253.03 | $33.78 | |
| Short term investments | $204.42 | $187.11 | $217.15 | |
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $290.15 | $331.8 | $442.78 | $253.07 |
| Long term investments | $99.09 | $9.81 | ||
| Property, plant & equipment | $115.03 | $116.92 | $117.88 | $119.28 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $222.29 | $134.16 | $125.81 | |
| Total investments | $303.51 | $196.92 | $217.15 | |
| Total assets | $532.03 | $554.09 | $576.94 | $378.88 |
| Current liabilities | ||||
| Accounts payable | $1.94 | $3.76 | $3.18 | $3.67 |
| Deferred revenue | ||||
| Short long term debt | $5.53 | $6.08 | $6.07 | |
| Total current liabilities | $22.47 | $20.86 | $22.19 | $23.33 |
| Long term debt | $80.04 | $81.1 | $82.27 | |
| Total noncurrent liabilities | $80.04 | $81.1 | $82.27 | |
| Total debt | $85.57 | $87.17 | $88.34 | |
| Total liabilities | $101.16 | $100.9 | $103.28 | $105.6 |
| Shareholders' equity | ||||
| Retained earnings | -$518.29 | -$489.94 | -$464.95 | -$435.43 |
| Other shareholder equity | -$0.26 | -$0.13 | $0.01 | |
| Total shareholder equity | $453.18 | $473.65 | $273.29 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $33.78 | $40.24 | $62.91 | $97.11 |
| Short term investments | $217.15 | $314.65 | $177.27 | $218.22 |
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $253.07 | $360.69 | $245.78 | $318.83 |
| Long term investments | ||||
| Property, plant & equipment | $119.28 | $107.66 | $24.53 | $17.86 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $125.81 | $112.25 | $28.12 | $18.82 |
| Total investments | $217.15 | $314.65 | $177.27 | $218.22 |
| Total assets | $378.88 | $472.94 | $273.9 | $337.65 |
| Current liabilities | ||||
| Accounts payable | $3.67 | $1.76 | $1.11 | $1.18 |
| Deferred revenue | ||||
| Short long term debt | $6.07 | $4.25 | $2.48 | $1.4 |
| Total current liabilities | $23.33 | $22.05 | $12.94 | $8.83 |
| Long term debt | $82.27 | $78.69 | $9.97 | $7.52 |
| Total noncurrent liabilities | $82.27 | $78.69 | $9.99 | $7.6 |
| Total debt | $88.34 | $82.93 | $12.46 | $8.92 |
| Total liabilities | $105.6 | $100.73 | $22.94 | $16.43 |
| Shareholders' equity | ||||
| Retained earnings | -$435.43 | -$317.93 | -$204.1 | -$118.02 |
| Other shareholder equity | $0.01 | -$0.68 | -$0.15 | $0 |
| Total shareholder equity | $273.29 | $372.21 | $250.97 | $321.22 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $23.13 | $25.24 | $23.32 | |
| Selling, general & administrative | $7.58 | $7.53 | $7.86 | |
| Total operating expenses | $33.79 | $30.71 | $32.76 | $31.18 |
| Operating income | -$30.71 | -$32.76 | -$31.18 | |
| Income from continuing operations | ||||
| EBIT | -$24.99 | -$29.52 | -$27.75 | |
| Income tax expense | ||||
| Interest expense | $5.45 | |||
| Net income | ||||
| Net income | -$28.34 | -$24.99 | -$29.52 | -$27.75 |
| Income (for common shares) | -$24.99 | -$29.52 | -$27.75 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $96.77 | $90.9 | $63.41 | $36.22 |
| Selling, general & administrative | $34.88 | $28.06 | $23.02 | $15.29 |
| Total operating expenses | $131.65 | $118.95 | $86.43 | $51.51 |
| Operating income | -$131.65 | -$118.95 | -$86.43 | -$51.51 |
| Income from continuing operations | ||||
| EBIT | -$117.5 | -$113.84 | -$86.08 | -$91.36 |
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | -$117.5 | -$113.84 | -$86.08 | -$91.36 |
| Income (for common shares) | -$117.5 | -$113.84 | -$86.08 | -$91.36 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$24.99 | -$29.52 | -$27.75 | |
| Operating activities | ||||
| Depreciation | $2.82 | $2.85 | $2.82 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $4.41 | $4.37 | $3.51 | |
| Total cash flows from operations | -$21.89 | -$28.51 | -$23.35 | |
| Investing activities | ||||
| Capital expenditures | -$2.35 | -$0.17 | -$6.81 | |
| Investments | -$105.27 | $21.66 | $22.64 | |
| Total cash flows from investing | -$125.03 | -$107.63 | $21.48 | $15.84 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$0.37 | $226.27 | $0.29 | |
| Net borrowings | ||||
| Total cash flows from financing | $225.9 | -$0.37 | $226.27 | $0.29 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $25.92 | -$129.89 | $219.25 | -$7.22 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$117.5 | -$113.84 | -$86.08 | -$91.36 |
| Operating activities | ||||
| Depreciation | $8.09 | $6.57 | $2.12 | $1.05 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $17.2 | $16.86 | $14.46 | $6.75 |
| Total cash flows from operations | -$86.16 | -$57 | -$67.93 | -$43.51 |
| Investing activities | ||||
| Capital expenditures | -$28.15 | -$47.11 | -$5.03 | -$7.51 |
| Investments | $107.16 | -$137.58 | $37.56 | -$202.57 |
| Total cash flows from investing | $79.02 | -$184.69 | $32.53 | -$210.08 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.69 | $219.01 | $1.48 | $265.5 |
| Net borrowings | ||||
| Total cash flows from financing | $0.69 | $219.01 | $1.2 | $329.82 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$6.45 | -$22.68 | -$34.19 | $76.23 |
News
Fundamentals
| Market cap | $182.77M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 70.57M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$110.61M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | -1.65 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$1.57 |
|---|---|
| ROA | -21.67% |
| ROE | N/A |
| Debt/Equity | 0.39 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 12.91 |
| Quick ratio | N/A |